Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease.
暂无分享,去创建一个
O. Dewit | A. Shitrit | J. Rahier | N. D. de Boer | Y. Vandermeeren | K. Katsanos | A. Dhar | T. Moreels | G. Costantino | N. Jojic | B. Bihin | F. Steinwurz | B. Alexandre | C. Ziady
[1] I. Serageldin,et al. Essentials , 2018, Make It Clear.
[2] E. Eggenberger. Initiation of anti-TNF therapy and the risk of optic neuritis: from the Safety Assessment of Biologic ThERapy (SABER) Study. , 2013, American journal of ophthalmology.
[3] Hidetoshi Takahashi,et al. Optic neuritis in a psoriatic arthritis patient treated by infliximab , 2013, The Journal of dermatology.
[4] J. Carvalho,et al. Optic neuritis after infliximab therapy , 2013, Rheumatology International.
[5] F. Bérard,et al. Optic neuritis associated with tumor necrosis factor-alfa antagonists for the treatment of psoriasis. , 2012, Journal of the American Academy of Dermatology.
[6] N. Saffra,et al. A case report of adalimumab-associated optic neuritis , 2012, Journal of Ophthalmic Inflammation and Infection.
[7] J. Gómez-Reino,et al. Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review. , 2011, Seminars in arthritis and rheumatism.
[8] J. Aasly. Bilateral Optic Neuritis Associated with the Use of Infliximab , 2011, Case Reports in Ophthalmological Medicine.
[9] R. Saxena,et al. Management of optic neuritis , 2011, Indian journal of ophthalmology.
[10] D. Miléa,et al. [Is it optic neuritis? Differential diagnosis]. , 2010, Revue neurologique.
[11] D. Goldstein,et al. Optic Neuritis Associated with Adalimumab in the Treatment of Uveitis , 2010, Ocular immunology and inflammation.
[12] C. Zois,et al. Neurologic manifestations in inflammatory bowel diseases: current knowledge and novel insights. , 2010, Journal of Crohn's & colitis.
[13] J. Chan,et al. Infliximab and anterior optic neuropathy: case report and review of the literature , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.
[14] K. Katsanos,et al. Reversible bilateral optic neuritis after Infliximab discontinuation in a patient with Crohn's disease. , 2009, Journal of Crohn's & colitis.
[15] H. Elloumi,et al. Retrobulbar optic neuritis associated with infliximab in a patient with Crohn's disease. , 2009, Journal of Crohn's & colitis.
[16] R. Manara,et al. Sudden visual loss in a child with juvenile idiopathic arthritis-related uveitis , 2009, British Journal of Ophthalmology.
[17] K. Katsanos,et al. Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: A prospective single‐center study , 2009, Inflammatory bowel diseases.
[18] P. Munkholm,et al. Occurrence of demyelinating diseases after anti-TNFα treatment of inflammatory bowel disease: A Danish Crohn Colitis Database study. , 2008, Journal of Crohn's & colitis.
[19] R. Benecke,et al. Cerebral MRI lesions and anti-tumor necrosis factor-alpha therapy , 2008, Journal of Neurology.
[20] T. Kohnen,et al. Anterior Optic Neuropathy Associated with Adalimumab , 2008, Ophthalmologica.
[21] J. Pikkel. Possible link between infliximab and optic neuritis. , 2008, The Israel Medical Association journal : IMAJ.
[22] L. Peyrin-Biroulet,et al. [Retrobulbar optic neuritis during infliximab treatment for ulcerative colitis]. , 2008, Gastroenterologie clinique et biologique.
[23] N. Mumoli,et al. Infliximab-induced retrobulbar optic neuritis. , 2007, QJM : monthly journal of the Association of Physicians.
[24] H. Erdem,et al. Optic neuritis occurring with anti-tumour necrosis factor α therapy , 2007 .
[25] Shunsuke Kobayashi,et al. New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients , 2006, Clinical Rheumatology.
[26] R. Turbin,et al. Adalimumab-associated optic neuritis , 2006, Journal of the Neurological Sciences.
[27] L. Provinciali,et al. CNS demyelination during anti–tumor necrosis factor alpha therapy , 2006, Journal of Neurology.
[28] L. Balcer. Clinical practice. Optic neuritis. , 2006, The New England journal of medicine.
[29] I. Avni,et al. Optic neuritis associated with etanercept therapy for juvenile arthritis. , 2006, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
[30] J. Borrás-Blasco,et al. Optic Neuritis with Concurrent Etanercept and Isoniazid Therapy , 2005, The Annals of pharmacotherapy.
[31] J. Lewis,et al. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. , 2005, Gastroenterology.
[32] M. Lauritzen,et al. A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis. , 2005, Neurology.
[33] M. Trojano,et al. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity. , 2005, Investigative ophthalmology & visual science.
[34] K. Papadakis,et al. Association of anti-tumor necrosis factor therapy with the development of multiple sclerosis. , 2005, Journal of clinical gastroenterology.
[35] B. Bodaghi,et al. Névrite optique rétrobulbaire associée au traitement par infliximab , 2005 .
[36] D. Milea,et al. [Optic neuritis associated with infliximab]. , 2005, Journal francais d'ophtalmologie.
[37] R. Gold,et al. Plasma exchange for severe optic neuritis , 2004, Neurology.
[38] J. Corbett. Experience of the optic neuritis treatment trial , 2004, Current Neurology and Neuroscience Reports.
[39] L. Mejico. Infliximab-associated retrobulbar optic neuritis. , 2004, Archives of ophthalmology.
[40] H. Herzenberg,et al. Retrobulbar optic neuritis associated with infliximab in a patient with Crohn disease. , 2004, Annals of internal medicine.
[41] B. Weinshenker,et al. Demyelination During Anti-Tumor Necrosis Factor &agr; Therapy With Infliximab for Crohn's Disease , 2004, Inflammatory bowel diseases.
[42] F. Ghanchi,et al. Inflammatory bowel disease and the eye. , 2003, Survey of ophthalmology.
[43] Michael Wall,et al. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. , 2003, Archives of ophthalmology.
[44] D. Miller,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Management of Acute Optic Neuritis , 2022 .
[45] R. Sergott,et al. Retrobulbar optic neuritis associated with infliximab. , 2002, Archives of ophthalmology.
[46] H. Völker‐Dieben,et al. Cheilitis granulomatosa and optic neuropathy as rare extraintestinal manifestations of Crohn's disease. , 2002, Journal of clinical gastroenterology.
[47] J. Richert,et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. , 2001, Arthritis and rheumatism.
[48] V. Martinelli,et al. Optic neuritis: differential diagnosis , 2001, Neurological Sciences.
[49] W. Robinson,et al. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? , 2001, Arthritis and rheumatism.
[50] W. K. Peterson,et al. A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis , 2001, Neurology.
[51] L. Melton,et al. Concurrence of inflammatory bowel disease and multiple sclerosis. , 2000, Mayo Clinic proceedings.
[52] S. Cole,et al. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. , 2000, Investigative ophthalmology & visual science.
[53] E. G. de la Concha,et al. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis , 1999, Neurology.
[54] H. Link,et al. Incidence of optic neuritis in Stockholm, Sweden 1990–1995: I. Age, sex, birth and ethnic-group related patterns , 1998, Journal of the Neurological Sciences.
[55] M. Brodsky,et al. Visual function 5 years after optic neuritis: Experience of the optic neuritis treatment trial , 1997 .
[56] H. Mcdevitt,et al. The role of TNFα and related cytokines in the development and function of the autoreactive T-cell repertoire , 1997 .
[57] L. Kurland,et al. Optic neuritis , 1995, Neurology.
[58] R. Beck,et al. The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial. , 1994, Ophthalmology.
[59] R. Beck,et al. Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group. , 1993, Archives of neurology.
[60] R. Beck,et al. Recovery from severe visual loss in optic neuritis. , 1993, Archives of ophthalmology.
[61] Neil R. Miller,et al. A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis , 1992 .
[62] C. Lowder,et al. Posterior segment manifestations of inflammatory bowel disease. , 1991, Ophthalmology.
[63] G. Striph,et al. Visual recovery in patients with optic neuritis and visual loss to no light perception. , 1991, American journal of ophthalmology.
[64] J. Rizzo,et al. Risk of developing multiple sclerosis after uncomplicated optic neuritis , 1988, Neurology.
[65] R. Burde,et al. Optic neuritis in inflammatory bowel disease. , 1984, Journal of clinical neuro-ophthalmology.
[66] J. Hermon-Taylor,et al. ASSOCIATION OF ULCERATIVE COLITIS WITH MULTIPLE SCLEROSIS , 1982, The Lancet.
[67] J. Gómez-Reino,et al. Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review. , 2011, Seminars in arthritis and rheumatism.
[68] M. Khamashta,et al. Autoimmune diseases induced by biological agents: a double-edged sword? , 2010, Autoimmunity reviews.
[69] L. Peyrin-Biroulet,et al. [Retrobulbar optic neuritis during infliximab treatment for ulcerative colitis]. , 2008, Gastroenterologie clinique et biologique.
[70] H. Erdem,et al. Optic neuritis occurring with anti-tumour necrosis factor alpha therapy. , 2007, Annals of the rheumatic diseases.
[71] Urso FORTE. Urso. HIGHLIGHTS OF PRESCRIBING INFORMATION , 2007 .
[72] M. Brodsky,et al. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. , 2004, American journal of ophthalmology.
[73] K Suzuki,et al. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. , 2001, Nature neuroscience.
[74] G. Wong,et al. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination , 1998, Nature Medicine.
[75] H. Mcdevitt,et al. The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire. , 1997, Research in immunology.